PVI Predictors in Laparoscopic Hysterectomy
Predictors of Pleth Variability Index During Laparoscopically Assisted Vaginal Hysterectomy
1 other identifier
observational
50
1 country
1
Brief Summary
This observational study investigates the predictors of Pleth Variability Index (PVI) changes in euvolemic patients undergoing laparoscopic-assisted vaginal hysterectomy (LAVH). The primary objective is to quantify changes in PVI (ΔPVI) across six intraoperative time points associated with positional shifts. Secondary objectives include identifying key predictors of significant PVI change (ΔPVI ≥ 5%), such as passive leg raising, Trendelenburg position, body mass index (BMI), and intraabdominal pressure. Additional variables including perfusion index, mean arterial pressure, bispectral index, skin temperature, age, and anesthetic agent will be evaluated as potential modulators. Findings aim to support individualized fluid management strategies in LAVH.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 5, 2025
CompletedFirst Submitted
Initial submission to the registry
May 7, 2025
CompletedFirst Posted
Study publicly available on registry
May 20, 2025
CompletedMay 20, 2025
May 1, 2025
29 days
May 7, 2025
May 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
ΔPVI (Change in Pleth Variability Index)
Absolute change in PVI (%) at each of six intraoperative time points relative to baseline.
Intraoperative period (~60-90 minutes)
Secondary Outcomes (8)
Proportion of patients with significant ΔPVI ≥ 5%
At any of the six predefined intraoperative time points: • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg • End of surgery (within 60-90 minutes after induction of anesthesia)
Effect of intraabdominal pressure on ΔPVI
At post-pneumoperitoneum and post-Trendelenburg time points (20-45 minutes after anesthesia induction)
Effect of body mass index on ΔPVI
ΔPVI measured at post-pneumoperitoneum and post-Trendelenburg time points (20-45 minutes after anesthesia induction)
Change in mean arterial pressure (MAP)
MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)
Change in perfusion index (PI)
MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)
- +3 more secondary outcomes
Interventions
"PVI is continuously monitored using the Masimo Radical-7 pulse oximetry device to evaluate respiratory variation in the plethysmographic waveform amplitude during laparoscopic-assisted vaginal hysterectomy (LAVH). No fluid intervention is applied; device use is for observational measurement of fluid responsiveness."
Eligibility Criteria
Adult female patients aged 19 to 70 years with ASA physical status I-III who are scheduled to undergo elective laparoscopic-assisted vaginal hysterectomy (LAVH) at Wonkwang University Hospital. All participants are screened during routine preoperative consultations and provide written informed consent prior to enrollment.
You may qualify if:
- adult females aged 19-70 years (American Society of Anesthesiologists physical status I-III) scheduled for elective LAVH.
You may not qualify if:
- emergency surgery, severe cardiac or pulmonary disease, renal failure, pregnancy, or conditions contraindicating fluid administration. Participants were consecutively recruited during preoperative consultations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wonkwang University School of Medicine Hospital
Iksan, Jeollabuk-do, 54538, South Korea
Study Officials
- STUDY DIRECTOR
Cheol Lee, M.D.,Ph.D
Wonkwang University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 7, 2025
First Posted
May 20, 2025
Study Start
April 1, 2025
Primary Completion
April 30, 2025
Study Completion
May 5, 2025
Last Updated
May 20, 2025
Record last verified: 2025-05